Research Article
Eya2 Is Overexpressed in Human Prostate Cancer and Regulates Docetaxel Sensitivity and Mitochondrial Membrane Potential through AKT/Bcl-2 Signaling
Table 1
Distribution of Eya2 status in prostate cancer according to clinicopathological characteristics.
| Characteristics | Number of patients | Eya2 low expression | Eya2 high expression | P |
| Age | | | | | <65 | 39 | 10 | 29 | 0.2288 | ≥65 | 59 | 22 | 37 | | TNM stage | | | | | I-II | 53 | 24 | 29 | 0.0038 | III-IV | 45 | 8 | 37 | | Gleason score | | | | | ≤7 | 29 | 14 | 15 | 0.0128 | >7 | 66 | 15 | 51 | | T stage | | | | | T1-T2 | 69 | 28 | 35 | 0.0008 | T3-T4 | 35 | 4 | 31 | | Lymph node metastasis | | | | | Absent | 71 | 23 | 48 | 0.4965 | Present | 24 | 6 | 18 | |
|
|